Open Access Articles

Joanne Lester
CJON 2012, 16(6), E192-E197 DOI: 10.1188/12.CJON.E192-E197
The use of hormonal, chemotherapeutic, and targeted biologic oral agents has exponentially increased since the early 2000s. Oral therapies have the advantage of persistent exposure of the cytotoxic drug to tumor cells and the tumor environment. The use of oral anticancer agents provides therapeutic...
0
No votes yet
Marlyn Allicock
Leanne Kaye
La-Shell Johnson
Carol Carr
Candice Alick
Mindy Gellin
Marci Campbell
CJON 2012, 16(5), E156-E163 DOI: 10.1188/12.CJON.E156-E163
Motivational interviewing (MI) as a counseling approach has gained empirical support for its use in a number of settings and for a variety of behaviors. However, the majority of practitioners trained to use MI have been professionals rather than laypeople. This article presents the rationale,...
0
No votes yet
Eric Zack
CJON 2012, 16(4), E125-E132 DOI: 10.1188/12.CJON.E125-E132
New trends have emerged in treating patients with autoimmune diseases with medications traditionally used in oncology. This article will summarize a comprehensive literature review performed to identify effective chemotherapy and biotherapeutic agents for treating each of the main autoimmune...
0
No votes yet
Rebecca H. Lehto
CJON 2012, 16(1), E4-E11 DOI: 10.1188/12.CJON.E1-E8
A new diagnosis of lung cancer is a highly threatening experience that raises personally relevant existential issues and brings death-related thoughts and concerns to mind. Those issues can be very disturbing to patients, leading to distress and potentially to a lowered quality of life. The purpose...
0
No votes yet
Mary Beth Steck
Julia A. Eggert
CJON 2011, 15(3), E34-E41 DOI: 10.1188/11.CJON.E34-E41
Genetic advancements have presented numerous discrimination predicaments to individuals, the healthcare community, and legislators at state and federal levels. Oncology nurses should be knowledgeable about the Genetic Information Nondiscrimination Act of 2008 (GINA) and its applications to clinical...
0
No votes yet
Journal Club
Open Access Article
Kathryn Trotter
Alana Frazier
Colleen K. Hendricks
Heidi Scarsella
CJON 2011, 15(2), E24-E33 DOI: 10.1188/11.CJON.E24-E33
The Centering Cancer Survivorship (CCS) follow-up care program is an innovation in healthcare delivery that meets the needs of cancer survivors and cancer centers. Piloted in a breast cancer clinic, the program provides an avenue for provision of psychological support and health-promotion...
0
No votes yet
Amy Edgington
Mary Ann Morgan
CJON 2011, 15(1), E3-E12 DOI: 10.1188/11.CJON.E3-E12
Cancer recurrence is a very real concern for cancer survivors. Surveillance for recurrence and vigilance for development of new cancers are top priorities during follow-up visits after active treatment ends. However, the cancer survivor also is at risk for the development of comorbid conditions...
0
No votes yet
Journal Club
Open Access Article
Carlton G. Brown
Cynthia Miller Murphy
Vicki Norton
Patricia Donahue Baldwin
Julie Ponto
CJON 2010, 14(6), E63-E69 DOI: 10.1188/10.CJON.E63-E69
The attainment of oncology nursing certification indicates that a nurse has the knowledge and expertise to competently care for patients with an actual or potential diagnosis of cancer. Research regarding the value nurses associate with certification is lacking; therefore, the Oncology Nursing...
0
No votes yet
Journal Club
Open Access Article
Patricia Potter
Teresa Deshields
Joyce Divanbeigi
Julie Berger
Doreen Cipriano
Lori Norris
Sarah Olsen
CJON 2010, 14(5), E56-E62 DOI: 10.1188/10.CJON.E56-E62
This descriptive, cross-sectional survey was conducted in inpatient nursing units and outpatient clinics in a cancer center in the midwestern United States. The sample of 153 healthcare providers included RNs, medical assistants, and radiology technicians. The fourth revision of the 30-item...
0
No votes yet
Ausanee Wanchai
Jane M. Armer
Bob R. Stewart
CJON 2010, 14(4), E45-E55 DOI: 10.1188/10.CJON.E45-E55
Patients with breast cancer use complementary and alternative medicine (CAM) despite the fact that no studies have shown altered disease progression attributable to CAM use. The purpose of this systematic review is to summarize research as it relates to CAM use among women with breast cancer. Among...
0
No votes yet